NOMAC : New Tools for Managing the Fate of Cereal Nutrients in the Gut : Effects of Amylose Content on Glycemic Index.
- Conditions
- Healthy
- Interventions
- Other: 20% amylose breadDietary Supplement: 10% amylose breadDietary Supplement: Carbohydrates
- Registration Number
- NCT01437917
- Lead Sponsor
- Rennes University Hospital
- Brief Summary
The consumption of cereals-based foods with low glycemic indexes, high micronutrients and fibers contents are highly recommended. The target of this work is to provide new solutions for cereal based foods: the knowledge and understanding on the in vivo fate will be used to define structural features to gain in foods.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 10
- Healthy individual,
- Age between 19-65 years
- With normal food habits with at least 2 main meals per day
- Non smoking
- Having filled the consent form
- BMI > 25 kg/m2,
- Diabetes or any illness susceptible to alter
- Coeliac disease
- Past history of intestinal diseases.
- Treatment susceptible of modifying glycemia.
- Allergy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Bread with 20% amylose content 20% amylose bread Bread with 20% amylose content Bread with 10% amylose content 10% amylose bread Bread with 10% amylose content carbohydrates Carbohydrates 50g of carbohydrates ingested with 400 ml of water
- Primary Outcome Measures
Name Time Method Glycemic index for each bread 2 hours To compare the glycemic index of breads made with different amylose content. (S1 to S6) A total of 6 visits. In each visit, blood samples will be taken for measurement of glycemia and insulinemia over 2 hours after ingestion of 50 of carbohydrates ingested with 400 ml of water.
- Secondary Outcome Measures
Name Time Method AUC for insulinemia for the 2 hours following the ingestion of each bread. 2 hours To compare the AUC for insulinemia for the 2 hours following the ingestion of each bread.
Trial Locations
- Locations (1)
Rennes University Hospital
🇫🇷Rennes, Bretagne, France